Efficacy and Safety of Bimatoprost 0.01% for the Treatment of Eyebrow Hypotrichosis

A randomized, double-blinded, vehicle-controlled trial involving 40 patients evaluated the efficacy and safety of bimatoprost 0.01% for treating eyebrow hypotrichosis over 6 months. The study found that bimatoprost 0.01% significantly increased eyebrow hair density, diameter, and clinical assessments compared to the placebo (p < .001). Patients reported higher satisfaction with bimatoprost (p < .05), and adverse effects were minimal and similar between groups. The study concluded that bimatoprost 0.01% is effective, safe, and well-tolerated for enhancing eyebrows.